High dose of primaquine in primaquine resistant vivax malaria. 1994

D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Bangkok, Thailand.

The efficacy of low dose chloroquine, characteristic pattern of relapse and the relapse rate in vivax malaria after high dose primaquine were investigated in 167 Thai patients. 87 patients were allocated at random to receive 300 mg, and 80 received 450 mg of chloroquine on the first day of admission. All patients in both groups showed a rapid response with comparable fever clearance times (27.3 vs. 26.1 h) and parasite clearance times (67.1 vs. 58.1 h). After recovery and clearance of parasitaemia, the patients were allocated at random (double blind) to receive 2 dosage regimens of primaquine, a daily dose of 15 mg or 22.5 mg for 14 d. Relapses in both groups occurred within 6 months; no patient relapsed beyond that period. The relapse rate in the primaquine 15 mg group was significantly higher than that in the 22.5 mg group (17.5% vs. 2.4%).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011319 Primaquine An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) Primacin,Primaquine Diphosphate,Primaquine Phosphate,Diphosphate, Primaquine,Phosphate, Primaquine
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
May 2008, The American journal of tropical medicine and hygiene,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
August 1992, Lancet (London, England),
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
December 1999, The American journal of tropical medicine and hygiene,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
August 1952, Journal of the American Medical Association,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
March 2022, The New England journal of medicine,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
July 2022, The New England journal of medicine,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
July 2022, The New England journal of medicine,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
January 2005, Journal of travel medicine,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
December 1997, Annals of tropical medicine and parasitology,
D Bunnag, and J Karbwang, and A Thanavibul, and S Chittamas, and Y Ratanapongse, and K Chalermrut, and K N Bangchang, and T Harinasuta
July 1961, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!